Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

A Phase 1 Multidose Study to Evaluate the Safety and Tolerability of XmAb®13676 in Patients with CD20-Expressing Hematologic Malignancies

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT02924402
Protocol Number
NSH1261
Phase
I
Management Group
BMT Program
Oncology Group
BMT Oncology Group
Disease Sites
Other Hematopoietic
Sponsor Protocol
XmAB13676
Principal Investigator
Melhem Solh
Scope
National
Participating Institutions
Northside Hospital - Atlanta (BMT)
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us